type here...

CATEGORIES

Blood Conditions

LATEST

123Page 2 of 3

TRENDING

EDITORS CHOICE

CAR T-mRNA Therapy For Cardiac Fibrosis: A New Way Forward

William Haseltine, PhD -
This is a series on the advances in CAR T, a remarkable immunotherapy treatment dubbed a “living drug.” This new therapy genetically modifies a patient’s cells to fight cancer, but current research efforts hope to treat autoimmune diseases, organ damage and more.

Addressing Global Income Disparities in Acute Lymphoblastic Leukaemia Care

Christopher Nial -
he stark disparity in the diagnosis and treatment of Acute Lymphoblastic Leukaemia (ALL) between high-income countries (HICs) and low- and middle-income countries (LMICs) highlights a critical issue in global healthcare equity.

Making Advanced Cancer a Chronic Disease

Michael Hunter, MD -
“CANCER SPREAD” HAS SUCH dreadful implications. Having helped individuals with cancer for over three decades, discussions around metastases still shake me. Fortunately, age-adjusted death rates are...

Can We Dare to Think about an End to AIDS?

Mark Chataway -
What would my 23-year-old self have made of my 63-year-old self moderating a session on the end of AIDS as a public health threat...

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories